|
|
Title | Creator | Date |
1 |
|
Cases of Ischemic Optic Neuropathy Associated With Phosphodiesterase-5 Inhibitor Use Reported to the Food and Drug Administration Adverse Event Reporting System | Howard D. Pomeranz, MD, PhD | 2016-06 |
2 |
|
Research Registries: A Tool to Advance Understanding of Rare Neuro-Ophthalmic Diseases | Kimberly D. Blankshain, BS; Heather E. Moss, MD, PhD | 2016-09 |
3 |
|
Association Between Phosphodiesterase-5 Inhibitors and Nonarteritic Anterior Ischemic Optic Neuropathy | Nawaaz A Nathoo; Mahyar Etminan; Frederick S Mikelberg | |
4 |
|
Diagnostic Features of Retinal Nerve Fiber Layer Rotation in Skew Deviation Using Optical Coherence Tomography | Chen, John J; Kardon, Randy H; Longmuir, Reid A | |
5 |
|
Dominant Optic Atrophy: How to Determine the Pathogenicity of Novel Variants? | Jason A. Zehden; Subahari Raviskanthan; Peter W. Mortensen; Marc Ferré; Pascal Reynier; Dan Milea; Andrew G. Lee | 2022-06 |
6 |
|
Validity of International Classification of Diseases Codes for Identifying Neuro-Ophthalmic Disease in Large Data Sets: A Systematic Review | Ali G. Hamedani, MD, MHS; Lindsey B. De Lott, MD, MS; Tatiana Deveney, MD; Heather E. Moss, MD, PhD | 2020-12 |
7 |
|
Increased Incidence of Pseudotumor Cerebri Syndrome Among Users of Tetracycline Antibiotics | Samuel F. Passi; Ryan Butcher; Daniel R. Orme; Judith E. A. Warner; Gregory J. Stoddard; Alison V. Crum; Ramkiran Gouripeddi; Brian H. Kirk; Kathleen B. Digre; Bradley J. Katz | 2022-09 |
8 |
|
Literature Commentary | Mark L. Moster, MD; Marc J. Dinkin, MD; Deborah I. Friedman, MD, MPH | 2022-12 |
9 |
|
Optic Nerve Abnormalities in Morning Glory Disc Anomaly: An MRI Study | Diem-Trang Nguyen; Nathalie Boddaert; Dominique Bremond-Gignac; Matthieu P. Robert | 2022-06 |
10 |
|
Baseline Retinal Nerve Fiber Layer Thickness and Macular Volume Quantified by OCT in the North American Phase 3 Fingolimod Trial for Relapsing-Remitting Multiple Sclerosis | Winges, Kimberly M; Werner, John S; Harvey, Danielle J; Cello, Kimberly E; Durbin, Mary K; Balcer, Laura J; Calabresi, Peter A; Keltner, John L | |
11 |
|
Deep Learning and Transfer Learning for Optic Disc Laterality Detection: Implications for Machine Learning in Neuro-Ophthalmology | T. Y. Alvin Liu; Daniel S. W. Ting; Paul H. Yi; Jinchi Wei; Hongxi Zhu; Prem S. Subramanian; Taibo Li; Ferdinand K. Hui; Gregory D. Hager; Neil R. Miller | 2020-06 |
12 |
|
Stroke Rate, Subtype, and Cardiovascular Risk Factors in Nonarteritic Anterior Ischemic Optic Neuropathy: A Population-Based Study | Robert C. Foster; M. Tariq Bhatti; Olivia M. Crum; Elizabeth R. Lesser; David O. Hodge; James P. Klaas; John J. Chen | 2020-09 |
13 |
|
Multifocal electroretinographic abnormalities in ethambutol-induced visual loss. | Liu, Yao; Dinkin, Marc J; Loewenstein, John I; Joseph F. Rizzo III, M.D.; Cestari, Dean M | |
14 |
|
Table of Contents | | |
15 |
|
Asymmetric Papilledema in Idiopathic Intracranial Hypertension | Samuel Bidot; Beau B Bruce; Amit M Saindane; Nancy J Newman; Valrie Biousse | |
16 |
|
Avoiding Clinical Misinterpretation and Artifacts of Optical Coherence Tomography Analysis of the Optic Nerve, Retinal Nerve Fiber Layer, and Ganglion Cell Layer | John J. Chen, MD, PhD; Randy H. Kardon, MD, PhD | 2016-12 |
17 |
|
Optic Neuritis Associated With Tumor Necrosis Factor-Alpha Inhibitor Certolizumab | Ariel Chen, MD; Neil R. Miller, MD; Thomas M. Bosley, MD | 2021-12 |
18 |
|
Table of Contents | | |
19 |
|
Table of Contents | | |
20 |
|
Table of Contents | | |
21 |
|
Table of Contents | | |
22 |
|
Antibody Development in Patients Treated Long-Term With OnabotulinumtoxinA for Benign Essential Blepharospasm and Hemifacial Spasm | Craig N. Czyz, DO; John A. Burns, MD; Reece E. Bergstrom, DO | 2021-12 |
23 |
|
Food and Drug Administration Adverse Event Reports of Retinal Vascular Occlusions Associated With Phosphodiesterase Type 5 Inhibitor Use | Albert S. Li, MD; Howard D. Pomeranz, MD, PhD | 2016-12 |
24 |
|
Best Catch from NANOSNET | Cornblath, WT; Calvert, PC | |
25 |
|
Literature Commentary | | |